Peter Groitl

Technical University of Munich — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index1.9kcitations49works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(34), interferon and immune responses(10), RNA Interference and Gene Delivery(8), Retinoids in leukemia and cellular processes(7), RNA Research and Splicing(6)

Publications49 total

Human Adenovirus (HAdV) mediated inhibition of the tumor suppressor p53 is controlled by SUMOylation of the viral E2A/DBP protein
2025
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53
Journal of Virology·2024· 4 citedOpen Access
SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA
Microbiology Spectrum·2023· 24 citedOpen Access
PML Alternative Splice Products Differentially Regulate HAdV Productive Infection
Microbiology Spectrum·2022· 12 citedOpen Access
Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers
mBio·2020· 30 citedOpen Access
ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity
Advanced Science·2020· 21 citedOpen Access
The human adenovirus type 5 E1B 55kDa protein interacts with RNA promoting timely DNA replication and viral late mRNA metabolism
PLoS ONE·2019· 6 citedOpen Access
Human Adenovirus Core Protein V Is Targeted by the Host SUMOylation Machinery To Limit Essential Viral Functions
Journal of Virology·2017· 12 citedOpen Access
Corrigendum to “Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis” [Biochimie 113C (2015) 10–16]
Biochimie·2015
Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis
Biochimie·2015· 4 cited
PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53
Oncogene·2015· 26 citedOpen Access
Adenovirus Replaces Mitotic Checkpoint Controls
Journal of Virology·2015· 12 citedOpen Access
Sp100 Isoform-Specific Regulation of Human Adenovirus 5 Gene Expression
Journal of Virology·2014· 54 citedOpen Access
SPOC1-Mediated Antiviral Host Cell Response Is Antagonized Early in Human Adenovirus Type 5 Infection
PLoS Pathogens·2013· 54 citedOpen Access
Targeted Suppression of Human Adenovirus DNA-polymerase Gene by RNA Interference
Investigative Ophthalmology & Visual Science·2013
Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes
Nucleic Acids Research·2013· 90 citedOpen Access
Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection
Cancer Gene Therapy·2012· 26 cited
The Adenoviral Oncogene E1A-13S Interacts with a Specific Isoform of the Tumor Suppressor PML To Enhance Viral Transcription
Journal of Virology·2012· 38 citedOpen Access
Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein
Oncogene·2012· 37 cited
Functional Cooperation between Human Adenovirus Type 5 Early Region 4, Open Reading Frame 6 Protein, and Cellular Homeobox Protein HoxB7
Journal of Virology·2012· 6 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Thomas Dobner(39), Sabrina Schreiner(19), Peter Wimmer(11), Paola Blanchette(9), Philip E. Branton(6), Martin Lipp(5), Thomas Speiseder(5), Julia Berscheminski(5), Thomas S. Weiß(5), Samuel Hofmann(5), Kathrin Kindsmüller(4), Ronald T. Hay(4), Julia Mai(4), Rania Dayoub(4), Anja‐Katrin Bosserhoff(4), Roger D. Everett(3), Hans Wolf(3), Berthold Henglein(3), H Synovzik(3), P. Hartl(3)